Citizens Business Bank’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.51M Sell
11,213
-265
-2% -$144K 0.9% 37
2025
Q4
$6.65M Buy
11,478
+228
+2% +$129K 1.1% 26
2025
Q3
$5.46M Buy
11,250
+4,996
+80% +$2.33M 0.91% 36
2025
Q2
$2.54M Buy
6,254
+42
+0.7% +$17.6K 0.49% 59
2025
Q1
$3.09M Buy
6,212
+1,348
+28% +$730K 0.67% 48
2024
Q4
$3.19M Sell
4,864
-1,452
-23% -$798K 0.6% 51
2024
Q3
$3.91M Sell
6,316
-169
-3% -$100K 0.79% 40
2024
Q2
$3.59M Sell
6,485
-167
-3% -$95.7K 0.76% 41
2024
Q1
$3.87M Sell
6,652
-141
-2% -$79.1K 0.81% 38
2023
Q4
$3.61M Sell
6,793
-179
-3% -$86.6K 0.79% 39
2023
Q3
$3.53M Sell
6,972
-237
-3% -$126K 0.83% 37
2023
Q2
$3.76M Sell
7,209
-270
-4% -$146K 0.84% 39
2023
Q1
$4.31M Sell
7,479
-342
-4% -$193K 0.99% 30
2022
Q4
$4.31M Sell
7,821
-80
-1% -$42.4K 0.99% 27
2022
Q3
$4.01M Sell
7,901
-118
-1% -$66K 0.98% 29
2022
Q2
$4.36M Buy
8,019
+8
+0.1% +$4.4K 0.62% 40
2022
Q1
$4.73M Buy
8,011
+605
+8% +$348K 0.57% 45
2021
Q4
$4.94M Buy
7,406
+29
+0.4% +$18.1K 0.61% 39
2021
Q3
$4.21M Sell
7,377
-7
-0.1% -$3.84K 0.56% 45
2021
Q2
$3.73M Sell
7,384
-56
-0.8% -$26.4K 0.49% 49
2021
Q1
$3.4M Sell
7,440
-103
-1% -$49.2K 0.48% 53
2020
Q4
$3.51M Sell
7,543
-2,534
-25% -$1.19M 0.52% 50
2020
Q3
$4.45M Sell
10,077
-13
-0.1% -$5.37K 0.76% 29
2020
Q2
$3.66M Sell
10,090
-222
-2% -$74.4K 0.65% 38
2020
Q1
$2.92M Sell
10,312
-100
-1% -$31.5K 0.6% 42
2019
Q4
$3.38M Sell
10,412
-59
-0.6% -$17.9K 0.56% 44
2019
Q3
$3.05M Sell
10,471
-70
-0.7% -$20K 0.5% 51
2019
Q2
$3.1M Sell
10,541
-244
-2% -$67.2K 0.51% 50
2019
Q1
$2.95M Buy
10,785
+209
+2% +$52K 0.51% 49
2018
Q4
$2.37M Sell
10,576
-411
-4% -$96.4K 0.46% 53
2018
Q3
$2.68M Sell
10,987
-42
-0.4% -$9.66K 0.45% 56
2018
Q2
$2.28M Sell
11,029
-5,674
-34% -$1.2M 0.4% 66
2018
Q1
$3.45M Buy
16,703
+35
+0.2% +$7.35K 0.6% 39
2017
Q4
$3.17M Sell
16,668
-5,882
-26% -$1.13M 0.52% 53
2017
Q3
$4.27M Sell
22,550
-468
-2% -$84.8K 0.71% 26
2017
Q2
$4.02M Sell
23,018
-583
-2% -$97.9K 0.67% 31
2017
Q1
$3.63M Sell
23,601
-187
-0.8% -$28.6K 0.61% 39
2016
Q4
$3.36M Sell
23,788
-373
-2% -$55K 0.6% 38
2016
Q3
$3.84M Sell
24,161
-238
-1% -$36.7K 0.71% 29
2016
Q2
$3.6M Buy
24,399
+883
+4% +$130K 0.68% 39
2016
Q1
$3.33M Sell
23,516
-1,435
-6% -$192K 0.62% 42
2015
Q4
$3.54M Sell
24,951
-2,520
-9% -$336K 0.69% 37
2015
Q3
$3.36M Sell
27,471
-545
-2% -$71K 0.63% 43
2015
Q2
$3.63M Sell
28,016
-190
-0.7% -$24.8K 0.63% 51
2015
Q1
$3.79M Buy
28,206
+680
+2% +$87.7K 0.67% 46
2014
Q4
$3.45M Buy
27,526
+1,354
+5% +$165K 0.63% 53
2014
Q3
$3.19M Buy
26,172
+492
+2% +$59.8K 0.61% 52
2014
Q2
$3.03M Sell
25,680
-872
-3% -$103K 0.58% 53
2014
Q1
$3.19M Buy
26,552
+18,398
+226% +$2.19M 0.62% 48
2013
Q4
$908K Buy
8,154
+2,945
+57% +$293K 0.18% 155
2013
Q3
$480K Buy
+5,209
New +$471K 0.1% 209

Other funds holding TMO

Citizens Business Bank's TMO Position: Q1 2026 in Review

Citizens Business Bank reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q1 2026, selling an estimated $144K and leaving 11,213 shares worth $5.51M. The position accounts for 0.9% of the portfolio, ranked #37.

Citizens Business Bank first reported a position in TMO in Q3 2013 and has held it in 51 quarters since. The position peaked at $6.65M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Citizens Business Bank held 11,213 shares of Thermo Fisher Scientific worth $5.51M as of Q1 2026.
  • Citizens Business Bank sold 265 Thermo Fisher Scientific shares in Q1 2026, an estimated $144K.
  • Thermo Fisher Scientific made up 0.9% of Citizens Business Bank's portfolio in Q1 2026, its #37 holding.
  • Citizens Business Bank first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 51 quarters since.
  • Citizens Business Bank's Thermo Fisher Scientific position peaked at $6.65M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Citizens Business Bank's 13F filing for Q1 2026, filed 1 May 2026.